Soobin Koh

Soobin Koh is a seasoned regulatory affairs professional specializing in oncology and vaccine development. Currently serving as a Global Regulatory Lead at Seagen, they manage IND submissions and clinical development planning, excelling in project management and multi-functional collaboration. Previously, Soobin held positions at Pfizer and Curevo Vaccine, focusing on regulatory compliance and documentation. They earned a Bachelor of Science in Biology and a Master's degree in Biomedical Regulatory Affairs from the University of Washington.